Clinical Trials Logo

Clinical Trial Summary

This is a randomized controlled pilot trial in approximately 50 acute coronary syndrome patients to determine if a 12 week, telephone-delivered, combined positive psychology-motivational interviewing intervention is feasible and more effective than a motivational interviewing health education program at improving health behaviors and other outcomes. The investigators hypothesize that the intervention will be associated with better mental and physical health outcomes and better health behavior adherence compared to the motivational interviewing health education program.


Clinical Trial Description

The initial study visit will occur in-person two weeks after discharge from the hospital. Participants will meet with a member of the study staff (the study "trainer") and complete self-report questionnaires assessing health behavior adherence and mental and physical health. Then, participants will be randomized to receive the positive psychology + motivational interviewing or the motivational interviewing health education interventions. A study interventionist will provide a treatment manual specific to their condition, review the rationale for the initial exercise, and assign the first exercise. If the participant is in the positive psychology + motivational interviewing condition, the trainer will explain the rationale for both the positive psychology and goal-setting portions of the program, and will be assigned the first exercise. Similarly, if the participant is randomized into the motivational interviewing health education program, the interventionist will introduce them to the program and assign the first exercise. Participants in both groups will then be given an accelerometer, which they will be asked to wear for 7 days to ensure that they are comfortable with the device and that useable data can be obtained from the participant. Participants in both groups will then complete twelve 30-minute weekly phone sessions with a study trainer. The phone sessions primarily will include a review of the prior week's session content and a discussion of the rationale and assignment of the next week's exercise/assignment. Upon the completion of these calls, and again at a final follow-up timepoint at 24 weeks, a blinded member of the study staff will call participants to administer self-report outcome measures. Participants will also be asked to wear an accelerometer at each of these follow-up timepoints as an objective measure of physical activity, which they will return by mail to the study staff. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03122184
Study type Interventional
Source Massachusetts General Hospital
Contact
Status Completed
Phase N/A
Start date May 1, 2017
Completion date November 26, 2018

See also
  Status Clinical Trial Phase
Recruiting NCT03273075 - Add-on Cangrelor in STEMI-triggered Cardiac Arrest Phase 4
Completed NCT03103620 - Safety and Effectiveness Evaluation of COBRA PzF Coronary Stent System: A Post Marketing Observational Registry
Recruiting NCT04222608 - The BRAvAdO Registry
Recruiting NCT06095557 - MCG Discovery Study in Emergency Departments N/A
Completed NCT04000490 - External Validation of the SCARE Score
Recruiting NCT04140019 - Early Cardiac Magnetic Resonance Imaging in Suspected Non-ST-Elevation Myocardial Infarction
Completed NCT04485754 - Telemedicine Follow-up for Post-ACS Patients N/A
Completed NCT03138473 - Impact of Residual Syntax Score and Syntax Revascularization Index on Outcomes of ACS Patients With Multi-Vessel Disease
Completed NCT04219761 - National Tunisian Registry of Percutaneous Coronary Intervention
Recruiting NCT03707496 - A Registry of De Winter Symdrome of Single Center
Terminated NCT04062383 - Positive Emotions After Acute Coronary Events at Northwestern University N/A
Recruiting NCT05378321 - Prevalence of NAFLD in ACS Patients N/A
Recruiting NCT03413410 - A Multi-Center Study on the Metoprolol Optimal Dosing Pathway of Metoprolol Application in Chinese Patients With Acute Coronary Syndrome N/A
Completed NCT03793582 - Impact of OSA on Outcomes in Acute Coronary Syndrome
Terminated NCT05323136 - Evaluate the Effects of Renal Impairment on the Pharmacokinetics and Pharmacodynamics Phase 1
Recruiting NCT06283888 - CYP2C19 Genotype-Guided P2Y12 Receptor Inhibitor Selection After Complex Percutaneous Coronary Intervention Phase 4